Background and purpose Aneurysm wall enhancement (AWE) of intracranial aneurysms on
magnetic resonance imaging has been described in previous studies as a surrogate marker …

Cerebrovascular diseases are a leading cause of disability and death worldwide. The
definition of stroke etiology is mandatory to predict outcome and guide therapeutic …

Background and Purpose: High-resolution vessel wall imaging (HR-VWI) is a powerful tool
in diagnosing intracranial vasculopathies not detected on routine imaging. We hypothesized …

Background and purpose Gadolinium enhancement on high-resolution vessel wall imaging
(HR-VWI) is an imaging marker of intracranial atherosclerotic stenosis (ICAS) plaque …

Aneurysm wall enhancement (AWE) after the administration of contrast gadolinium is a
potential biomarker of unstable intracranial aneurysms. While most studies determine AWE …

Background Intracranial fusiform aneurysms are complex and poorly characterized vascular
lesions. High-resolution magnetic resonance imaging (HR-MRI) and computational …

Vessel wall enhancement (VWE) in contrast-enhanced magnetic resonance imaging (MRI)
is a potential biomarker for intracranial aneurysm (IA) risk stratification. In this study, we …

Objective This cross-sectional study aimed to investigate the associations between
aneurysm wall enhancement (AWE), atherosclerotic protein levels, and aneurysm size in …

Background Aneurysm wall enhancement (AWE) is a potential surrogate biomarker for
aneurysm instability. Previous studies have assessed AWE using 2D multiplanar methods …

OBJECTIVE Inflammation plays an integral role in the formation, growth, and progression to
rupture of unruptured intracranial aneurysms (UIAs). Animal and human studies have …